The antibody according to the present invention, particularly a monoclonal antibody including any functionally equivalent antibody or functional parts thereof, thus preferentially binds to polymeric soluble amyloid and oligomeric amyloid peptides, respectively, particularly to soluble polymeric A?? peptides and oligomeric A?? peptides comprising a plurality of A??1-42 monomeric peptides, respectiv